Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haichen Yang

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
Epilepsia|February 27, 2009
Adjunctive levetiracetam in infants and young children with refractory partial-onset seizuresJesus Eric Piña-Garza, Douglas R Nordli, Dietz Rating, et al.
Clinical Therapeutics|November 25, 2010
Adjunctive levetiracetam in patients aged 1 month to <4 years with partial-onset seizures: subpopulation analysis of a prospective, open-label extension study of up to 48 weeksJesus Eric Piña-Garza, Jimmy Schiemann-Delgado, Haichen Yang, et al.
Epilepsy Research|May 24, 2017
Effect of enzyme inhibition on perampanel pharmacokinetics: Why study design mattersBarry E Gidal, Rama Maganti, Antonio Laurenza, et al.
Epilepsia|November 22, 2016
Analysis of falls in patients with epilepsy enrolled in the perampanel phase III randomized double-blind studiesIlo E Leppik, Haichen Yang, Betsy Williams, et al.
Epilepsy & Behavior : E&B|May 3, 2014
The practical impact of altered dosing on perampanel plasma concentrations: pharmacokinetic modeling from clinical studiesBarry E Gidal, Oneeb Majid, Jim Ferry, et al.
Neurology|April 17, 2015
Perampanel efficacy and tolerability with enzyme-inducing AEDs in patients with epilepsyBarry E Gidal, Antonio Laurenza, Ziad Hussein, et al.
Epilepsia|August 22, 2012
Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global phase III study 305Jacqueline A French, Gregory L Krauss, Bernhard J Steinhoff, et al.
The Clinical Respiratory Journal|October 14, 2014
Sertraline hydrochloride treatment for patients with stable chronic obstructive pulmonary disease complicated with depression: a randomized controlled trialYuanqiang He, Yulong Zheng, Chuanqin Xu, et al.
Plos One|April 8, 2026
Impact of the stress hyperglycemia ratio on short-term outcomes in critically ill patients with chronic kidney disease: A comparative analysis of diabetic and non-diabetic populationsXia Li, Zhikun Zhao, Xinyuan Zhang, et al.
Journal of Child Neurology|August 31, 2011
A long-term open-label extension study assessing cognition and behavior, tolerability, safety, and efficacy of adjunctive levetiracetam in children aged 4 to 16 years with partial-onset seizuresJimmy Schiemann-Delgado, Haichen Yang, Christine de la Loge, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Epilepsia|February 27, 2009
Adjunctive levetiracetam in infants and young children with refractory partial-onset seizuresJesus Eric Piña-Garza, Douglas R Nordli, Dietz Rating, et al.
Clinical Therapeutics|November 25, 2010
Adjunctive levetiracetam in patients aged 1 month to <4 years with partial-onset seizures: subpopulation analysis of a prospective, open-label extension study of up to 48 weeksJesus Eric Piña-Garza, Jimmy Schiemann-Delgado, Haichen Yang, et al.
Epilepsy Research|May 24, 2017
Effect of enzyme inhibition on perampanel pharmacokinetics: Why study design mattersBarry E Gidal, Rama Maganti, Antonio Laurenza, et al.
Epilepsia|November 22, 2016
Analysis of falls in patients with epilepsy enrolled in the perampanel phase III randomized double-blind studiesIlo E Leppik, Haichen Yang, Betsy Williams, et al.
Epilepsy & Behavior : E&B|May 3, 2014
The practical impact of altered dosing on perampanel plasma concentrations: pharmacokinetic modeling from clinical studiesBarry E Gidal, Oneeb Majid, Jim Ferry, et al.
Neurology|April 17, 2015
Perampanel efficacy and tolerability with enzyme-inducing AEDs in patients with epilepsyBarry E Gidal, Antonio Laurenza, Ziad Hussein, et al.
Epilepsia|August 22, 2012
Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global phase III study 305Jacqueline A French, Gregory L Krauss, Bernhard J Steinhoff, et al.
The Clinical Respiratory Journal|October 14, 2014
Sertraline hydrochloride treatment for patients with stable chronic obstructive pulmonary disease complicated with depression: a randomized controlled trialYuanqiang He, Yulong Zheng, Chuanqin Xu, et al.
Plos One|April 8, 2026
Impact of the stress hyperglycemia ratio on short-term outcomes in critically ill patients with chronic kidney disease: A comparative analysis of diabetic and non-diabetic populationsXia Li, Zhikun Zhao, Xinyuan Zhang, et al.
Journal of Child Neurology|August 31, 2011
A long-term open-label extension study assessing cognition and behavior, tolerability, safety, and efficacy of adjunctive levetiracetam in children aged 4 to 16 years with partial-onset seizuresJimmy Schiemann-Delgado, Haichen Yang, Christine de la Loge, et al.
Pageof 8